Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

70.91
-1.1800-1.64%
Pre-market: 71.090.1800+0.25%07:31 EDT
Volume:3.08M
Turnover:216.76M
Market Cap:9.86B
PE:-9.87
High:71.79
Open:71.54
Low:69.31
Close:72.09
52wk High:88.31
52wk Low:44.91
Shares:139.02M
Float Shares:138.02M
Volume Ratio:1.68
T/O Rate:2.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-56.82
PE(LYR):-10.84

Loading ...

Cytokinetics director B. Lynne Parshall disposes of USD 370,400 in common shares

Reuters
·
Jun 02

Cytokinetics - Myqorzo Launched in Germany Following European Commission Approval in February 2026

THOMSON REUTERS
·
Jun 01

Cytokinetics Launches Myqorzo® (Aficamten) in European Union, With First Commercial Availability in Germany

THOMSON REUTERS
·
Jun 01

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

GlobeNewswire
·
Jun 01

Cytokinetics Announces Launch of Myqorzo (Aficamten) in Germany for Symptomatic Obstructive Hypertrophic Cardiomyopathy

THOMSON REUTERS
·
Jun 01

Cytokinetics CEO Makes Major Move With Fresh Stock Sale

TIPRANKS
·
May 29

Cytokinetics CEO Robert I. Blum sells 7,500 shares for $579,075

Reuters
·
May 29

Cytokinetics Shareholders Reinforce Board and Governance Frameworks

TIPRANKS
·
May 28

Cytokinetics shareholders elect three Class I directors at annual meeting

Reuters
·
May 28

Cytokinetics to Participate in June Investor Conferences

GlobeNewswire
·
May 28

Top Cytokinetics Executive Makes Notable Move With Fresh Stock Sale

TIPRANKS
·
May 21

Cytokinetics EVP R&D Malik sells 3,500 shares for $264,915‬

Reuters
·
May 21

Cytokinetics announces annual stockholders meeting

Reuters
·
May 21

Cytokinetics to Hold Annual Meeting of Stockholders

THOMSON REUTERS
·
May 21

How New Aficamten Phase 3 Data and Equity Raise Will Impact Cytokinetics (CYTK) Investors

Simply Wall St.
·
May 19

Cytokinetics Initiated at Buy by Citigroup

Dow Jones
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

Cytokinetics initiated with a Buy, named a top pick at Citi

TIPRANKS
·
May 19

Cytokinetics grants 20,807 stock options at USD 75.85 under inducement plan

Reuters
·
May 19

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
May 19